Eye on Lithium: ERW, FRS and these other ASX lithium stocks crushed it in May. Here’s why
How about a handful of the most notable lithium-based stocks to perform in May? (Yes, there were quite a few, lithium doubters). Read on… [more…]
Property: There’s no more homes left to sell in Perth, Adelaide or Brisbane.
Homeowners are winning again, after winning constantly for many decades and especially over the last year and a half CoreLogic reports its monthly measure of [more…]
Closing Bell: ASX gains as house prices keep climbing; cash is dead as Armaguard falters
ASX starts June positively, extending May gains Property prices in Australia rose by 0.8% in May, with Sydney remaining the most expensive city Lovisa plunges [more…]
Brightstar’s plus-30,000m drilling blitz enters Phase 2
Last batch of assays from Brightstar Resources’ Link Zone at the Menzies Gold Project return up to 29g/t gold 52 holes complete at Lady Shenton, [more…]
Testing adds confidence to heap leach option for Red Metal’s rare earths discovery
Phase 2 metallurgical test work adds confidence to low-cost, low-capital heap leach processing at Sybella Interim results show strong REO recoveries on coarser heap leach [more…]
ASX Small Caps Lunch Wrap: Who’s talking big about a brand-new crack this week?
Local markets were up this morning, partly because Wall Street did okay on Friday night, and partly because the ASX spent the weekend with its [more…]
Resources Top 4: Kincora majorly boosts gold and copper hunt in NSW’s Macquarie Arc
Kincora Copper has secured the Wongarbon project in the gold-copper-rich Macquarie Arc, in central NSW Eastern Metals meanwhile targets high priority base metal zones in [more…]
Resourceful Argent eyes silver streak, rakes in $2.5m
Critical minerals explorer and developer Argent has now completed a $2.5m capital raise The funds will be used to advance its Kempfield polymetallic project in [more…]
AdAlta secures $1.9m from exercise of options to advance critical discovery programs
1AD raises $1.9 million of new equity from the exercise of listed 1ADOA options, led by an existing major shareholder Options exercised at a 20% [more…]
ASX Health Stocks: INOVIQ pops 45pc after revealing breakthrough exosome therapy to kill breast cancer
INOVIQ’s exosomes therapy to target breast cancer cells INOVIQ (ASX:IIQ) said it has created specialised exosomes (EEVs) designed to target and destroy breast cancer cells [more…]
